OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Bradley Hyman

1 Projects | 1 Researchers | $250,000 Invested

2013

Harvard Medical School

Bradley Hyman, MD, PhD

APOE2-based gene therapy approaches to alleviate Alzheimer's disease neuropathological hallmarks

  • Funding Amount: $250,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: zzAPOE
  • Status: Closed